Reaf International Corp - NY New York, New York City 10027

Reaf International Corp entered the industry of Mail Order Pharmaceuticals in 2004 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 454113, which describes it as a Mail Order Pharmaceuticals. For further clarification, the SIC classifies this business under the code 5961 and described it as a Mail Order Pharmaceuticals. The business provides service to the B2C market.

To acquire more information, please contact Toney Orubuloye by calling (212) 316-1100 during business hours. You can also write to the business’ Single Location at 1405 Amsterdam Avenue, New York City, New York NY 10027. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Reaf International Corp
Representative: Toney Orubuloye
Place of Business: 1405 Amsterdam Avenue, New York City, NY 10027
Contact Number: (212) 316-1100
Type of Service: Mail Order Pharmaceuticals
SIC Number: 5961
NAICS Number: 454113
Locality: Single Location
Market Type: B2C (Business to Consumer)
Began: 2004
Income/Year: $100.000 to $499.999
Laborers: 1 to 4
Share This Company:

Reaf International Corp is a company operating from New York, New York providing professional Mail Order Pharmaceuticals and relevant B2C variables. It was founded in 2004 and registered with the SIC code 5961 as Mail Order Pharmaceuticals, and with the NAICS code 454113 as Mail Order Pharmaceuticals.

With a current employee count of 1 to 4, Reaf International Corp has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Toney Orubuloye at (212) 316-1100 for related queries, or to locate its Single Location using the coordinates .

The Single Location can also be found at the street address 1405 Amsterdam Avenue in New York City, New York 10027 and can be engaged online through the company website at , the company Twitter , and Facebook page .